首页> 美国卫生研究院文献>Experimental and Therapeutic Medicine >Multiple drug resistance due to resistance to stem cells and stem cell treatment progress in cancer (Review)
【2h】

Multiple drug resistance due to resistance to stem cells and stem cell treatment progress in cancer (Review)

机译:癌症对干细胞的耐药性和干细胞治疗进展导致多重耐药性(综述)

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In recent years, the cancer stem cell (CSC) theory has provided a new angle in the research of cancer, and has gradually gained significance. According to this theory, the multiple drug resistance (MDR) of cancer is most likely due to the resistance of CSCs, and a significant quantity of research has been carried out into the MDR mechanisms of CSC. Over time, some of these mechanisms have been gradually accepted, including ATP-binding cassette transporters, aldehyde dehydrogenase, the CSC microenvironment and epithelial to mesenchymal transition. In the present review, we summarize these mechanisms in detail and review possible appropriate therapy plans against CSCs based on CSC theory.
机译:近年来,癌症干细胞(CSC)理论为癌症研究提供了新的视角,并逐渐具有重要意义。根据该理论,癌症的多药耐药性(MDR)最可能是由于CSC的耐药性,并且已经对CSC的MDR机制进行了大量研究。随着时间的流逝,这些机制中的一些已被逐渐接受,包括ATP结合盒转运蛋白,醛脱氢酶,CSC微环境和上皮向间质转化。在本综述中,我们详细总结了这些机制,并根据CSC理论回顾了针对CSC的可能的适当治疗方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号